Cell Therapy: A New M&A Frontier
Cellares co-founder and CEO Fabian Gerlinghaus shares his unique approach to developing successful cell therapies
GrowthTV
Why Secondaries Are in the Spotlight
Preqin's Cameron Joyce shares why secondaries are key to market adjustments
Keep Healthcare Costs from Eating Your Earnings
QBE North America's Tara Krauss shares insights from the 2023 Accident and Health Market Report
How Can Corporates Compete with PE and Win?
Rheem Manufacturing's Ryan Mullin debunks myths about strategics
What Attracts Investors to Agtech
Stonehenge Capital's Brandon Pettagrue discusses the agtech opportunity ahead of ACG's AgTech Investor Symposium
GF Data Report: Q2 Brings Record Low Deal Volume
Bob Dunn of GF Data reflects on Q2's challenging dealmaking environment
Creating KPIs that Actually Drive Value
Trive Capital shares how dealmakers can maximize their ROI
The Unique Value Proposition of First Nation Investors
Fort McKay discusses the opportunity for private equity to collaborate with Indigenous investors
How to Become a More Resilient Business
Insperity joins GrowthTV to discuss improving the speed and effectiveness of your firm’s crisis response